Point-of-Care (POC) Diagnostics: Transformation From Pre- to Post- Pandemic: An Asian Perspective

Authors: Dr. Shaillender M, Engagement Manager, EVERSANA APAC; Robin Arnold, Executive Vice President, EVERSANA APAC; Aditya Prakash, Consultant, EVERSANA APAC

The pandemic significantly accelerated the adoption and technological advancement of point-of-care (POC) diagnostics, transforming them from niche applications to common household tools. This POV document explores the evolution of POC diagnostics, highlighting three key categories: POC rapids, POC immunoassays (IA), and POC molecular diagnostics (MD). It discusses their technological differentiation, market growth, and the impact of major acquisitions in the industry. The document also examines the post-pandemic landscape, emphasizing the need for new growth vectors and the integration of POC diagnostics into broader healthcare ecosystems, including remote care and telemedicine.

Discover how POC diagnostics are set to become a staple of modern healthcare, driving faster diagnosis, treatment, and personalized care. Complete the form below to download the full article.